Home > Insider Trading > Novavax Inc

Novavax Inc (NVAX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

BofA Reiterates Hold Rating on Novavax (NVAX) Stock

The approval of Nuvaxovid for use in older and high-risk adults will generate around $175 million in milestone payments from Sanofi during Q3 and an additional $50 million in the second half of 2025.

Keep Reading →

May 21st, 2025 - News

BTIG Maintains a Buy rating on Novavax (NVAX)

The approval marks a significant milestone for Novavax Inc. (NASDAQ:NVAX), aligning with the changing regulatory landscape after the pandemic.

Keep Reading →

May 20th, 2025 - News

JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News

On May 19, JPMorgan analyst Eric Joseph reaffirmed an Underweight rating for Novavax Inc. (NASDAQ:NVAX) with a price target of $7.

Keep Reading →

May 19th, 2025 - News

FDA Clears Novavax, Inc. (NVAX)'s COVID-19 Vaccine with Usage Restrictions

Previously available under emergency use authorization for individuals aged 12 and up, the shot is now fully approved only for adults 65 and older, or for those between the ages of 12 and 64 who have ...

Keep Reading →

May 18th, 2025 - News

10 Unstoppable Stocks That Could Double Your Money

Generating significant returns and multiplying their money in the stock market remains a primary goal for most investors.

Keep Reading →

April 4th, 2025 - Hedge Funds News

11 High-Risk High-Reward Growth Stocks To Buy Now

The stock market has an ever-changing environment, leaving investors constantly looking for opportunities that promise substantial returns for their investments.

Keep Reading →

March 28th, 2025 - Hedge Funds Market Movers News

Novavax, Inc. (NASDAQ:NVAX) Q4 2024 Earnings Call Transcript

Operator: Good morning and welcome to Novavax Fourth Quarter 2024 Financial Results and Operational Highlights Conference Call. All participants will be in listen-only mode.

Keep Reading →

February 28th, 2025 - News Transcripts

10 Under-the-Radar Stocks with Massive Upside for 2025

Investing in under-the-radar stocks can be a savvy move for those looking to diversify their portfolios and potentially reap significant rewards.

Keep Reading →

January 20th, 2025 - Hedge Funds News

Why Vaccine Stocks, Lucid (LCID) Are Rallying

The Louisiana Department of Health noted yesterday that a 65-year-old hospital patient had died due to bird flu.

Keep Reading →

January 7th, 2025 - Market Movers News

Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript

Operator: Good morning and welcome to Novavax' Third Quarter 2024 Financial Results and Operational Highlights Conference Call. All participants will be in listen-only mode.

Keep Reading →

November 13th, 2024 - News Transcripts